Any disease-defining genetic alterations exclude the diagnosis of MPN-U, such as BCR-ABL1 and PCM1-JAK2, and rearrangements of PDGFRA, PDGFRB, or FGFR1. [146]. The gene discussed is PDGFRA; the disease is myeloproliferative neoplasm.